These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 23567428)
41. Costs and quality of life of multiple sclerosis in Germany. Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337 [TBL] [Abstract][Full Text] [Related]
42. The relation between disease severity and cost of caring for patients with Alzheimer disease in Canada. Herrmann N; Tam DY; Balshaw R; Sambrook R; Lesnikova N; Lanctôt KL; Can J Psychiatry; 2010 Dec; 55(12):768-75. PubMed ID: 21172097 [TBL] [Abstract][Full Text] [Related]
43. Cost of dementia: impact of disease progression estimated in longitudinal data. Andersen CK; Lauridsen J; Andersen K; Kragh-Sørensen P Scand J Public Health; 2003; 31(2):119-25. PubMed ID: 12745762 [TBL] [Abstract][Full Text] [Related]
44. [The future economic burden of dementia on health and social services]. Sørensen J; Gudex CM; Andersen CK Ugeskr Laeger; 2006 Oct; 168(40):3432-6. PubMed ID: 17032611 [TBL] [Abstract][Full Text] [Related]
45. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Williams MM; Xiong C; Morris JC; Galvin JE Neurology; 2006 Dec; 67(11):1935-41. PubMed ID: 17159097 [TBL] [Abstract][Full Text] [Related]
46. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy. Fillit H; Hill JW; Futterman R Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008 [TBL] [Abstract][Full Text] [Related]
47. Comparison of costs of care between patients with Alzheimer's disease and dementia with Lewy bodies. Zhu CW; Scarmeas N; Stavitsky K; Albert M; Brandt J; Blacker D; Sano M; Stern Y Alzheimers Dement; 2008 Jul; 4(4):280-4. PubMed ID: 18631979 [TBL] [Abstract][Full Text] [Related]
48. Resource Use and Cost of Alzheimer's Disease in France: 18-Month Results from the GERAS Observational Study. Rapp T; Andrieu S; Chartier F; Deberdt W; Reed C; Belger M; Vellas B Value Health; 2018 Mar; 21(3):295-303. PubMed ID: 29566836 [TBL] [Abstract][Full Text] [Related]
49. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective. Rice DP; Fillit HM; Max W; Knopman DS; Lloyd JR; Duttagupta S Am J Manag Care; 2001 Aug; 7(8):809-18. PubMed ID: 11519239 [TBL] [Abstract][Full Text] [Related]
50. Pre-diagnosis excess acute care costs in Alzheimer's patients among a US Medicaid population. Geldmacher DS; Kirson NY; Birnbaum HG; Eapen S; Kantor E; Cummings AK; Joish VN Appl Health Econ Health Policy; 2013 Aug; 11(4):407-13. PubMed ID: 23700254 [TBL] [Abstract][Full Text] [Related]
51. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis]. Wolfenstetter SB Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820 [TBL] [Abstract][Full Text] [Related]
52. Resource use and economic impact of patients with gout: a multicenter, population-wide study. Sicras-Mainar A; Navarro-Artieda R; Ibáñez-Nolla J Reumatol Clin; 2013; 9(2):94-100. PubMed ID: 23313534 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus. Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311 [TBL] [Abstract][Full Text] [Related]
54. Net economic costs of dementia in Canada. Ostbye T; Crosse E CMAJ; 1994 Nov; 151(10):1457-64. PubMed ID: 7954140 [TBL] [Abstract][Full Text] [Related]
55. [Costs deriving from strokes from a social perspective. A retrospective incidence approach with a follow-up at three years]. Hervás-Angulo A; Cabasés-Hita JM; Forcén-Alonso T Rev Neurol; 2006 Nov 1-15; 43(9):518-25. PubMed ID: 17072806 [TBL] [Abstract][Full Text] [Related]
56. Economic impact of dementia in developing countries: an evaluation of Alzheimer-type dementia in Shanghai, China. Wang G; Cheng Q; Zhang S; Bai L; Zeng J; Cui PJ; Zhang T; Sun ZK; Ren RJ; Deng YL; Xu W; Wang Y; Chen SD J Alzheimers Dis; 2008 Sep; 15(1):109-15. PubMed ID: 18780971 [TBL] [Abstract][Full Text] [Related]
57. Determinants of societal costs in Alzheimer's disease: GERAS study baseline results. Dodel R; Belger M; Reed C; Wimo A; Jones RW; Happich M; Argimon JM; Bruno G; Vellas B; Haro JM Alzheimers Dement; 2015 Aug; 11(8):933-45. PubMed ID: 25846298 [TBL] [Abstract][Full Text] [Related]
58. Healthcare utilization and costs in primary care patients with dementia: baseline results of the DelpHi-trial. Michalowsky B; Flessa S; Eichler T; Hertel J; Dreier A; Zwingmann I; Wucherer D; Rau H; Thyrian JR; Hoffmann W Eur J Health Econ; 2018 Jan; 19(1):87-102. PubMed ID: 28160100 [TBL] [Abstract][Full Text] [Related]
59. Consequences of Anosognosia on the Cost of Caregivers' Care in Alzheimer's Disease. Turró-Garriga O; Garre-Olmo J; Reñé-Ramírez R; Calvó-Perxas L; Gascón-Bayarri J; Conde-Sala JL J Alzheimers Dis; 2016 Oct; 54(4):1551-1560. PubMed ID: 27636844 [TBL] [Abstract][Full Text] [Related]
60. Ascertaining Out-of-Pocket Costs of Dementia Care: Feasibility Study of a Web-Based Weekly Survey. Dawson WD; Mattek N; Gothard S; Kaye J; Lindauer A JMIR Form Res; 2024 Sep; 8():e56878. PubMed ID: 39321453 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]